| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10897359 | Cancer Epidemiology | 2014 | 8 Pages |
Abstract
Our results demonstrate that OPSCC patients with the KRAS-LCS6 variant have a better outcome and suggest that this variant may be used as a prognostic biomarker for OPSCC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Kim De Ruyck, Fréderic Duprez, Liesbeth Ferdinande, Chamberlain Mbah, Emmanuel Rios-Velazquez, Frank Hoebers, Marleen Praet, Philippe Deron, Katrien Bonte, Ernst-Jan Speel, Louis Libbrecht, Wilfried De Neve, Philippe Lambin, Hubert Thierens,